Verenium Corporation (VRNM) Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2012  
11/9/2012 9:57:31 AM

SAN DIEGO, Nov. 8, 2012 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today reported operating highlights and financial results for the third quarter and nine months ended September 30, 2012.